This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kilkenny, D. M. Articles by Rocheleau, J. V. Search for Related Content PubMed PubMed Citation Articles by Kilkenny, D. M. Articles by Rocheleau, J. V.

Fibroblast Growth Factor Receptor-1 Signaling in Pancreatic Islet β-Cells Is Modulated by the Extracellular Matrix

Cell Imaging Shared Resource (D.M.K.) and Molecular Physiology and Biophysics (J.V.R.), Vanderbilt University Medical Center, Nashville, Tennessee 37232-0615

Address all correspondence and requests for reprints to: Jonathan V. Rocheleau, 702 Light Hall, Vanderbilt University Medical Center, Nashville, Tennessee 37232-0615. E-mail: Jon.Rocheleau{at}vanderbilt.edu.

Maintenance of pancreatic β-cell mass depends on extracellular stimuli that promote survival and proliferation. In the islet, these stimuli come from the β-cell microenvironment and include extracellular matrix deposited by associated vascular endothelial cells. Fibroblast growth factor receptor-1 (FGFR1) has recently been implicated as a signaling pathway that is important for normal β-cell function. We would like to understand how extracellular matrix and FGFR1 signaling interact to promote β-cell survival and proliferation. To examine β-cell-specific receptor responses, we created lentiviral vectors with rat insulin promoter-driven expression of Venus fluorescent protein-tagged full-length (R1βv) and kinase-deficient (KDR1βv) FGFR1. Significant FGF-1-dependent activation of ERK1/2 was observed in βTC3 cells, dispersed β-cells, and β-cells in intact islets. This response was enhanced by R1βv expression and reduced by KDR1βv expression. Plating-dispersed β-cells on collagen type IV resulted in enhanced expression of endogenous FGFR1 that was associated with sustained activation of ERK1/2. Conversely, plating cells on laminin reduced expression of FGFR1, and this reduction was associated with transient activation of ERK1/2. Addition of neutralizing antibodies to inhibit β-cell attachment to laminin via ₆-integrin increased high-affinity FGF-1-binding at the plasma membrane and resulted in sustained ERK1/2 activity similar to cells plated on collagen type IV. These data show that the FGF-stimulated β-cell response is negatively affected by ₆-integrin binding to laminin and suggest regulation associated with vascular endothelial cell remodeling.

This article has been cited by other articles:

				N. Grarup, G. Andersen, N. T. Krarup, A. Albrechtsen, O. Schmitz, T. Jorgensen, K. Borch-Johnsen, T. Hansen, and O. Pedersen Association Testing of Novel Type 2 Diabetes Risk Alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 Loci With Insulin Release, Insulin Sensitivity, and Obesity in a Population-Based Sample of 4,516 Glucose-Tolerant Middle-Aged Danes Diabetes, September 1, 2008; 57(9): 2534 - 2540. [Abstract] [Full Text] [PDF]